A Retrospective Focus on Glioblastoma Treatment and Bevacizumab
From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.